Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic

An Observational Study to Identify the Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic and the Resulting Lockdown

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04406844

Enrollment

150

Registered

2020-05-28

Start date

2020-05-09

Completion date

2021-06-30

Last updated

2020-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oncology Patients

Brief summary

In view of increasing cases of SARS-CoV-2 leading to the COVID-19 Pandemic in India,there has been unprecedented restrictions on travel, work and other aspects of daily life. Our study has been designed to collect data of cancer patients to analyze their issues and challenges during Covid-19 Pandemic.

Detailed description

Protocol No: Onco\_Covid-19 Version no:1.0 Objectives: Firstly the patients recently diagnosed with cancer will be selected for enrollment who are on active treatment during lockdown based on the date of their registration in the hospital. This is followed by a telephonic interview with patients or their attendant to carry out a prospective, cross-sectional, observational study in order to address the issues and challenges faced by them during Lockdown. Collection of data will be done through telephonic communication. Participation in this study will be entirely voluntary. Telephonic verbal consent will be taken from the patients or their attendants before collection of their response on the study questionnaire and then will be asked questions accordingly based on the questionnaire which is available in English and Hindi both. Data and general information regarding participants will only be collected in questionnaire. No personal data of the participants will be taken which will also be conveyed to the participant or attendant during telephonic verbal consent.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

12 Years to 98 Years

Healthy volunteers

Inclusion criteria

* Registered with the Max Institute of Cancer Care between Nov 1st 2019 to Jan 31st 2020 * Were scheduled to receive one or more modalities of treatment (chemotherapy, surgery, radiation therapy, immunotherapy) during the period Feb 1st 2020 to April 30th 2020

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
Oncology patients	4-8 weeks	To focus on basic issues encountered by oncology patients such as transportation, medical facility, healthcare support, disease apprehension etc

Countries

India

Contacts

Primary ContactRajesh Saxena

rajesh.saxena@maxhealthcare.com9818474003

Outcome results